These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3094946)

  • 1. The new contrast agents: a perspective.
    Bettmann MA
    Cardiovasc Intervent Radiol; 1986; 9(4):173-5. PubMed ID: 3094946
    [No Abstract]   [Full Text] [Related]  

  • 2. New contrast media.
    Med Lett Drugs Ther; 1987 Apr; 29(738):43-4. PubMed ID: 3574237
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrotoxicity of iohexol, iopamidol and ioxaglate.
    Tverdal A; Haider T
    Can Assoc Radiol J; 1991 Jun; 42(3):226-7. PubMed ID: 2054686
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with low osmolar contrast media a clinical and experimental study.
    Pokorny L; Nagy E; Vadon G
    Ann Radiol (Paris); 1989; 32(1):40-2. PubMed ID: 2742325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procoagulant and anticoagulant effects of intravascular contrast media as assessed by thromboelastography.
    Iqbal O; Jeske W; Hoppensteadt D; Koza M; Walenga JM; Fareed J; Moncada R
    Semin Thromb Hemost; 1995; 21 Suppl 4():86-90. PubMed ID: 8747695
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of high- and low-osmolar contrast media on renal plasma flow and glomerular filtration rate in euvolaemic and dehydrated rats. A comparison between ioxithalamate, iopamidol, iohexol and ioxaglate.
    Nygren A; Ulfendahl HR
    Acta Radiol; 1989; 30(4):383-9. PubMed ID: 2775601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three new low-osmolality contrast agents: a comparative study of patient discomfort.
    Smith DC; Yahiku PY; Maloney MD; Hart KL
    AJNR Am J Neuroradiol; 1988; 9(1):137-9. PubMed ID: 3124566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell aggregability and contrast media. Recent results of quantitative dynamic ultrasonic analysis.
    Kallio T; Alanen A; Kormano M
    Invest Radiol; 1990 Sep; 25 Suppl 1():S121-2. PubMed ID: 2283228
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of low osmolarity contrast media in state of the art roentgen diagnosis].
    Pokorny L; Kiss I; Karcsú S; Nehéz I; Feledi J; Vadon G
    Orv Hetil; 1989 Jun; 130(25):1317-21. PubMed ID: 2664636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
    Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of clot formation with ionic and nonionic contrast media in cerebral angiography. Tama Contrast Media Study Group.
    Sato E; Saito I
    Acad Radiol; 1996 Nov; 3(11):925-8. PubMed ID: 8959182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
    Lasser EC; Lyon SG; Berry CC
    Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant effects of nonionic versus ionic contrast media in angiography syringes.
    Grabowski EF; Kaplan KL; Halpern EF
    Invest Radiol; 1991 May; 26(5):417-21. PubMed ID: 2055738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity of hydrosoluble iodine contrast media.
    Caillé JM; Allard M
    Invest Radiol; 1988 Sep; 23 Suppl 1():S210-2. PubMed ID: 3058631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative tolerability of contrast media used for coronary interventions.
    Esplugas E; Cequier A; Gomez-Hospital JA; Del Blanco BG; Jara F
    Drug Saf; 2002; 25(15):1079-98. PubMed ID: 12452733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do nonionic contrast media increase red cell aggregation and clot formation?
    Aspelin P
    Invest Radiol; 1990 Sep; 25 Suppl 1():S119-20. PubMed ID: 2283226
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse reactions during intravenous urography: are these due to histamine release?
    Herd CM; Robertson AR; Frewin DB; Taylor WB
    Br J Radiol; 1988 Jan; 61(721):5-11. PubMed ID: 2450612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-medium-induced ventricular fibrillation: arrhythmogenic mechanisms and the role of antiarrhythmic drugs in dogs.
    Idée JM; Matalon C; Koeltz B; Bonnemain B; Lefevre T
    Acad Radiol; 1996 Sep; 3(9):781-5. PubMed ID: 8883521
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the side-effects of low-osmolar contrast media in intravenous urography.
    Foord KD; Kaye B; Howard J; Cumberland DC
    Clin Radiol; 1985 Jul; 36(4):379-80. PubMed ID: 4064528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in renal function immediately after the angiography].
    Murakami R; Tajima H; Kumazaki T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jun; 54(7):605-12. PubMed ID: 8065882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.